Balanced Pharma Inc

New Filing

CIK: 0001838860·Pharmaceuticals·DELAWARE·Filed: Jan 15, 2025

Total Offering

$2,000,000

Amount Sold

$175,000

Investors

2

First Sale

Dec 31, 2024

Offering Details

Type: Equity
Exemptions: Rule 506(b)
Entity Type: Corporation
Year Incorporated: 2020
Non-Accredited Investors: No

Related Persons

Name	Role
JOHN SCOTT KEADLE	Related Person
JOHN SELIG	Related Person
ATIF ZIA	Related Person
MARK SEBREE	Related Person

Company

Balanced Pharma Inc

18204 MAINSAIL POINTE

CORNELIUS, NC, 28031

(704) 650-0249

SEC Filing

0001838860-25-000001

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.